Abstract
Eight organo-iron ferrocene derivatives and arenocenium salts were prepared and evaluated by "in vitro" assay against one strain of Trypanosoma cruzi (Y). Six of the eight organo-iron compounds assayed, piperazinium diferrocenoate 1, η6-(o-xylene)-η5-(cyclopentadienyl) Iron(II) hexafluorophosphate 3, η6-(mesitylene)-η5-(cyclopentadienyl) iron(II) hexafluorphosphate 5, η6-(durene)-η5-(cyclopentadienyl) iron(II) hexafluorphosphate 6, η6-(ρ-chlorotoluene)-η5-(cyclopentadienyl) Iron(II) hexafluorphosphate 7 and η6-(chlorobenzene)-η5-(cyclopentadienyl) iron(II) picrate 8, were poorly active in the "in vitro" assays. Only two compounds 1,1′-(N-pyperidinocarbonyl) ferrocene 2 (IC50=2.4 μg/mL) and η6-(o-xylene)-η5-(cyclopentadienyl) iron(II) picrate 4 (IC50=12.08 μg/mL), were more active. Thus, some of the compounds are promising to be used against Chagas' disease as a prophylactic agents.
Cite
CITATION STYLE
E Silva, M. L. A., Neto, A. F., Cardoso, S. A., Albuquerque, S., & Miller, J. (2001). Synthesis and “in vitro” trypanocidal activity evaluation of some organo-iron compounds. Metal-Based Drugs, 8(6), 329–332. https://doi.org/10.1155/MBD.2002.329
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.